Clinical Scorecard: Faster, Reliable, Patient-centered: What’s Next for SPECTRALIS®
At a Glance
| Category | Detail |
|---|---|
| Condition | Ophthalmic imaging and diagnostics |
| Key Mechanisms | Enhanced imaging speed, noise reduction, and customizable workflows |
| Target Population | Patients requiring retinal imaging, including those with macular atrophy and glaucoma |
| Care Setting | Clinics, hospitals, and research centers |
Key Highlights
- Introduction of SHIFT 250 kHz OCTA scan speed for tailored imaging protocols
- New Green Autofluorescence Module for improved visualization of retinal conditions
- Enhanced TruTrack Active Eye Tracking for stable imaging during scans
- Low Luminance Autofluorescence mode for light-sensitive patients
- Custom scan presets and multiselect report printing for improved workflow efficiency
Guideline-Based Recommendations
Diagnosis
- Utilize Green Autofluorescence for assessing macular atrophy and Stargardt’s disease
- Employ Change Analysis on Glaucoma Module for tracking structural changes in glaucoma
Management
- Implement low-luminance imaging for light-sensitive patients to enhance comfort
Monitoring & Follow-up
- Track changes in the Ganglion Cell Complex over time using Posterior Pole Change Analysis
Risks
- Consider patient comfort and light sensitivity when selecting imaging parameters
Patient & Prescribing Data
Elderly, pediatric, and low-vision individuals requiring retinal imaging
Faster scans and reduced light exposure improve patient comfort and diagnostic access
Clinical Best Practices
- Standardize imaging protocols across clinics using custom scan presets
- Utilize multiselect report printing to streamline documentation and reporting
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
